Showing results (71-80 of 115) with videos related to

Sort By:
Pageof 12
Oncology Letters|October 30, 2020
Profiling of inhibitory immune checkpoints in glioblastoma: Potential pathogenetic playersSalvo Danilo Lombardo, Alessia Bramanti, Rosella Ciurleo, et al.
Experimental and Therapeutic Medicine|October 1, 2017
Evaluation of hyaluronic acid-P40 conjugated cream in a mouse model of dermatitis induced by oxazoloneKatia Mangano, Franca Vergalito, Santa Mammana, et al.
Cancer Biology & Therapy|January 18, 2006
Detection of BRAF gene mutation in primary choroidal melanoma tissueGrazia Malaponte, Massimo Libra, Pietro Gangemi, et al.
International Journal of Immunopathology and Pharmacology|October 11, 2021
A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodiesGabriela Athziri Sánchez-Zuno, Mónica Guadalupe Matuz-Flores, Guillermo González-Estevez, et al.
Brain Sciences|October 23, 2019
Overexpression of Macrophage Migration Inhibitory Factor and Its Homologue D-Dopachrome Tautomerase as Negative Prognostic Factor in NeuroblastomaEugenio Cavalli, Emanuela Mazzon, Santa Mammana, et al.
Molecules (Basel, Switzerland)|May 13, 2023
Anti-COVID-19 Potential of Ellagic Acid and Polyphenols of Punica granatum LRalitza Alexova, Simona Alexandrova, Stela Dragomanova, et al.
Brain Sciences|April 3, 2020
Transcriptomic Analysis Reveals Abnormal Expression of Prion Disease Gene Pathway in Brains from Patients with Autism Spectrum DisordersSalvo Danilo Lombardo, Giuseppe Battaglia, Maria Cristina Petralia, et al.
Pharmaceuticals (Basel, Switzerland)|December 1, 2019
Effects of Treatment with the Hypomethylating Agent 5-aza-2'-deoxycytidine in Murine Type II Collagen-Induced ArthritisMaria Cristina Petralia, Emanuela Mazzon, Maria Sofia Basile, et al.
Oncotarget|March 2, 2018
Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosisSanta Mammana, Placido Bramanti, Emanuela Mazzon, et al.
Journal of Neuroimmunology|May 18, 2019
Prevention of clinical and histological signs of MOG-induced experimental allergic encephalomyelitis by prolonged treatment with recombinant human EGFFerdinando Nicoletti, Emanuela Mazzon, Paolo Fagone, et al.
Pageof 12